A direct niacin test is rarely the best way to assess vitamin B3 status. Clinicians usually diagnose suspected deficiency from symptoms, diet, medication history, and—when needed—urinary N1-methylnicotinamide plus targeted blood tests that identify the cause.
- Direct niacin test: Serum niacin is not a routine or well-standardized measure of nutritional status; urinary metabolites are more informative when deficiency is suspected.
- Urinary N1-methylnicotinamide: A 24-hour result below 0.5 mg/day, approximately 3.2 µmol/day, supports severe niacin depletion when collection is complete.
- Pellagra diagnosis: Pellagra remains primarily a clinical diagnosis based on characteristic photosensitive dermatitis, gastrointestinal symptoms, neurocognitive change, risk factors, and response to treatment.
- Vitamin B3 requirement: Adults generally need 14 mg niacin equivalents/day for women and 16 mg/day for men; 60 mg dietary tryptophan supplies roughly 1 mg niacin equivalent.
- Supplement limit: The adult tolerable upper intake level of 35 mg/day applies to supplemental nicotinic acid, not niacin naturally present in food.
- High-dose niacin: Nicotinic acid at 1,000–2,000 mg/day can affect liver enzymes, glucose, uric acid, and muscle symptoms, so clinicians monitor routine labs rather than a niacin level.
- Kidney function matters: Reduced eGFR can alter urinary metabolite excretion and makes a spot urine result less reliable than the clinical context.
- Do not self-treat neurologic symptoms: Confusion, severe diarrhoea, spreading photosensitive rash, jaundice, or weakness after high-dose supplements merits prompt medical review.
What a niacin test can—and cannot—show
A niacin test rarely gives a simple “vitamin B3 level.” Direct serum niacin measurement is uncommon, poorly standardized for everyday nutrition, and can change with a recent meal or supplement. In my clinical experience, suspected deficiency is assessed through symptoms, risk factors, urinary metabolites, and routine labs that explain why depletion developed.
Niacin is converted into NAD and NADP, coenzymes used in oxidation-reduction reactions throughout the body. A transient plasma concentration does not reliably show tissue stores, much as a single sip of water does not measure a person’s hydration over a week. Kantesti is an AI blood test analyzer that places related results—such as glucose, liver enzymes, albumin, and kidney function—into the clinical context a standalone vitamin number lacks.
Adults need 14 mg niacin equivalents (NE) daily for women and 16 mg NE daily for men; pregnancy raises the target to 18 mg NE/day and breastfeeding to 17 mg NE/day. One niacin equivalent is supplied by 1 mg preformed niacin or approximately 60 mg dietary tryptophan, which is why adequate protein intake can partly protect against deficiency.
A normal-looking routine blood panel does not exclude early dietary insufficiency, but a person eating normally with no rash, persistent diarrhoea, neurocognitive symptoms, alcohol dependence, malabsorption, or high-risk medication exposure seldom needs vitamin B3 levels checked. Dr. Thomas Klein’s practical rule is simple: test when the answer will alter the diagnostic work-up or treatment plan, not merely to create a number.
When clinicians consider niacin deficiency testing
Niacin deficiency testing is most useful when pellagra is plausible or when malnutrition and malabsorption are substantial. It is not part of routine wellness screening for asymptomatic adults with a varied diet.
Testing becomes reasonable with the classic pellagra cluster: symmetric sun-exposed dermatitis, persistent diarrhoea, and cognitive or mood change. The three features do not always arrive together; dermatitis and sore mouth may precede confusion by weeks. For an overview of other nutrient-related neurologic patterns, compare the thiamine testing guide.
Higher-risk settings include severe alcohol-use disorder, food insecurity, prolonged restrictive eating, active inflammatory bowel disease, coeliac disease, chronic diarrhoea, dialysis, and conditions that divert tryptophan metabolism, including carcinoid syndrome. I also think about B3 depletion after extensive gastrointestinal surgery or when a patient has been relying on maize as a dietary staple without traditional alkali processing.
Certain medicines change the pre-test probability rather than proving deficiency. Isoniazid can impair vitamin B6-dependent tryptophan conversion to niacin, while long courses of some immunosuppressive or antimetabolite medicines may compound poor intake. A medication list, weight trend, alcohol history, and a 7-day food record are often more diagnostically valuable than ordering a broad nutrient panel.
Urine markers used for vitamin B3 status
Twenty-four-hour urinary N1-methylnicotinamide is the most established laboratory marker of recent niacin adequacy. Very low excretion supports depletion, but the test must be interpreted alongside kidney function, collection quality, diet, and supplements.
N1-methylnicotinamide, also called 1-MN or NMN, is a urinary niacin metabolite measured by selected nutrition and metabolic laboratories. Historical public-health criteria classify 24-hour excretion below 0.5 mg/day as severe deficiency and 0.5–1.59 mg/day as low; 1.6 mg/day or more is generally compatible with adequate recent availability. A carefully completed 24-hour urine collection matters more than a precise-looking but incomplete sample.
Some laboratories report 1-MN per gram of urine creatinine from a spot sample, which helps partly correct for urine dilution. That adjustment has limits: low muscle mass, acute kidney injury, chronic kidney disease, and an unusually dilute specimen can all distort the ratio. There is no universal spot-urine cutoff that can replace the reporting laboratory’s own reference interval.
The related metabolite 2-pyridone may be measured with 1-MN in research-oriented assays, and the combined pattern can improve dietary assessment. In a patient with an eGFR below 30 mL/min/1.73 m², I would be particularly cautious about declaring deficiency from urine excretion alone; reduced clearance changes what reaches the collection container.
Which blood tests help when vitamin B3 is suspected
Blood tests in suspected vitamin B3 deficiency look for consequences and competing diagnoses, not a universally accepted niacin concentration. CBC, metabolic panel, albumin, glucose, inflammatory markers, and selected nutrient tests often produce the actionable information.
Whole-blood NAD and NADP measurements exist, but they are largely specialized or research assays with no harmonized adult reference range. A result can be affected by specimen handling because pyridine nucleotides degrade and redistribute after collection. That is why an isolated commercial “NAD level” should not be treated as a diagnostic test for pellagra.
A full blood count may show anaemia or macrocytosis from coexisting folate or B12 deficiency, while a low albumin can signal protein-energy undernutrition or systemic illness rather than niacin deficiency itself. A borderline B12 result deserves its own evaluation; see our guide to the B12 reference range.
Kantesti AI interprets uploaded routine panels by grouping nutrition-relevant findings rather than claiming that normal sodium, haemoglobin, or albumin rules out vitamin B3 deficiency. A low albumin, rising creatinine, low phosphate, and unexplained weight loss together are much more concerning than any one value alone—particularly in someone with months of diarrhoea.
Why pellagra diagnosis remains primarily clinical
Pellagra diagnosis is clinical because no single blood or urine result confirms or excludes it. Characteristic skin changes, gastrointestinal symptoms, neuropsychiatric symptoms, nutritional risk, and improvement after appropriate treatment carry more weight than a single metabolite result.
Pellagra dermatitis is typically symmetric, sharply demarcated, and worsens on sun-exposed or friction-prone areas. The neck distribution sometimes called Casal’s necklace, rough dorsal hands, and a painful red tongue are useful clues, although eczema, lupus, porphyria, zinc deficiency, and medication reactions can look similar. Hegyi, Schwartz, and Hegyi describe this diagnostic pattern in their 2004 review of pellagra (Hegyi et al., 2004).
Diarrhoea in pellagra can be intermittent rather than dramatic, and the neurological component may begin as irritability, poor concentration, insomnia, or depression before disorientation appears. I have seen patients labelled with “stress” for months when a careful nutrition history revealed substantial weight loss and an extremely narrow food repertoire.
Response to clinician-directed nicotinamide can support the diagnosis, but it should not end the search for the cause. Persistent diarrhoea, anaemia, or low ferritin after symptoms improve should trigger a malabsorption work-up; our article on faecal fat testing explains one route clinicians use when impaired fat and nutrient absorption is suspected.
What causes low vitamin B3 status
Low vitamin B3 status usually reflects inadequate intake, poor absorption, altered tryptophan metabolism, or substantial chronic illness. A low urine metabolite is a clue to investigate these mechanisms, not a final diagnosis.
Protein-poor diets can lower niacin equivalents because tryptophan is a precursor for endogenous niacin production. The approximate conversion is 60 mg tryptophan to 1 mg niacin equivalent, but this varies with vitamin B6 status, energy intake, and illness. A person consuming adequate calories but very little protein may therefore have a different risk profile from someone with transient appetite loss.
Malabsorption deserves attention when low B3 status appears alongside chronic loose stools, bloating, unexplained iron deficiency, or weight loss. Coeliac disease, Crohn’s disease, pancreatic insufficiency, and post-surgical short bowel can each reduce nutrient availability; symptoms of poor digestion merit a broader digestive laboratory review.
Alcohol use can lower intake, damage absorption, and displace other nutrients at the same time. The reason clinicians worry about combined low phosphate, low magnesium, low potassium, and recent nutritional restart is refeeding risk—not merely a missing vitamin—so electrolyte correction and nutrition support must be coordinated carefully.
How clinicians assess excess niacin exposure
Niacin excess is assessed from dose, formulation, symptoms, and safety labs—not from a high vitamin B3 blood level. Most clinically meaningful excess comes from nicotinic acid supplements or prescriptions in gram doses, rather than food.
The tolerable upper intake level for adults is 35 mg/day of supplemental nicotinic acid, a threshold based mainly on flushing; it does not apply to niacin naturally occurring in food. Prescription lipid regimens have historically used 1,000–2,000 mg/day, which is 29–57 times the supplemental upper limit and requires medical supervision.
Flushing, warmth, itching, headache, and light-headedness commonly occur shortly after immediate-release nicotinic acid. Sustained-release products can cause less flushing yet carry a disproportionate hepatotoxicity concern, which is one reason I advise patients not to swap formulations on their own. Read more about supplement decisions in our high-cholesterol supplement safety guide.
Kantesti is an AI lab test interpretation service that flags the pattern of raised ALT or AST, glucose change, uric acid elevation, and a reported high-dose supplement exposure as a reason for clinician follow-up. It cannot determine whether a dose is appropriate for an individual or replace medication monitoring.
Safety labs to check with high-dose nicotinic acid
ALT, AST, bilirubin, fasting glucose or HbA1c, uric acid, and sometimes creatine kinase are the core safety tests for high-dose nicotinic acid. Testing intervals depend on dose, formulation, baseline disease, symptoms, and the prescriber’s protocol.
ALT or AST values above three times a laboratory’s upper reference limit require prompt clinical assessment, particularly with fatigue, nausea, dark urine, right-upper abdominal discomfort, or jaundice. Bilirubin and alkaline phosphatase help distinguish hepatocellular from cholestatic patterns, while GGT can provide useful context; see GGT ranges by sex.
Nicotinic acid can worsen insulin resistance and raise glucose, so a person with diabetes or prediabetes often needs fasting glucose and HbA1c reviewed after dose changes. HbA1c reflects roughly the preceding 8–12 weeks of glycaemia; it will not immediately show a problem from a supplement started last Tuesday.
High-dose niacin can increase uric acid and precipitate gout in susceptible people. The evidence for adding niacin to effective statin therapy is unfavourable: the AIM-HIGH trial found no incremental cardiovascular benefit, and HPS2-THRIVE found more serious adverse events with extended-release niacin plus laropiprant (Boden et al., 2011; Landray et al., 2014).
Lab patterns that change the vitamin B3 work-up
A vitamin B3 investigation changes direction when routine tests suggest malnutrition, liver disease, kidney impairment, anaemia, or active gastrointestinal loss. The pattern determines whether urinary testing is useful and which specialist evaluation comes next.
Haemoglobin below the laboratory range with an MCV above 100 fL suggests macrocytosis, which more often points to B12, folate, alcohol exposure, liver disease, hypothyroidism, or medication effects than isolated niacin deficiency. That distinction prevents a common mistake: treating every nutrition-related rash with one vitamin while missing the broader deficiency pattern. Our haemoglobin result guide explains how CBC findings are read together.
Albumin below 35 g/L may support poor nutrition or protein loss but is also a negative acute-phase reactant, so it commonly falls during inflammation. I do not use albumin alone to label a patient malnourished; weight trajectory, dietary intake, CRP, liver synthetic function, and urine protein provide a more honest assessment.
Dr. Thomas Klein has found that a modest creatinine rise can be the hidden reason a urinary vitamin marker looks odd. When eGFR is reduced, a clinician may prioritize the metabolic panel, urinalysis, medication review, and nutrition history over repeating a specialized urine marker.
When diarrhoea and weight loss need broader testing
Chronic diarrhoea or unintentional weight loss alongside suspected niacin deficiency requires evaluation for the underlying gastrointestinal disorder. Vitamin replacement alone may improve symptoms temporarily while the actual absorptive problem continues.
Diarrhoea lasting more than 4 weeks is chronic and usually warrants a structured review, especially if it occurs with weight loss, nocturnal stools, anaemia, low albumin, fever, or visible blood. Coeliac serology, stool inflammatory markers, pancreatic elastase, infection tests, and endoscopy are chosen from the symptom pattern rather than ordered indiscriminately.
Pancreatic insufficiency is more likely when stools are bulky, greasy, difficult to flush, and associated with low body weight or fat-soluble vitamin deficits. A low stool elastase can help, although a watery stool may falsely lower it; our stool elastase guide covers this practical limitation.
A 38-year-old with chronic loose stools, a photosensitive rash, ferritin of 9 ng/mL, and albumin of 32 g/L needs a malabsorption evaluation even if a niacin supplement improves the rash within days. That combined pattern is more informative than a single B3 value and should not be written off as dietary preference.
How to prepare for urine or blood testing
Preparation for a niacin test depends on the assay, but preserving the real clinical picture is usually more useful than trying to “improve” the result. Do not stop prescribed treatment unless the ordering clinician specifically asks you to.
A 24-hour urine collection begins by discarding the first morning urine, then collecting every subsequent urine passed—including the next morning’s first sample—over the stated 24 hours. Missing even one substantial void can falsely lower total 1-MN excretion. Collection containers, refrigeration, and any preservative instructions are laboratory-specific.
Record all supplements for at least 7 days before testing, including multivitamins, energy products, fortified drinks, “NAD boosters,” and lipid medicines. A same-day 500 mg nicotinic acid tablet may markedly affect a metabolite result but does not show whether the person had adequate status over the preceding month.
Fasting is not universally required for urinary 1-MN testing, but it may be required when glucose, lipids, or other safety markers are drawn simultaneously. Our guide to supplements before fasting blood work explains why biotin, minerals, and vitamin products can complicate some assays.
What to do with a low or unusual niacin result
A low urinary niacin metabolite should prompt confirmation of collection quality and a search for dietary, gastrointestinal, medication, alcohol-related, or renal explanations. It should not automatically lead to a high-dose supplement regimen.
An unexpectedly low 1-MN result with normal intake may reflect an incomplete collection, dilute or mishandled sample, low creatinine excretion, or kidney disease. A clinician may repeat the collection, use a laboratory-specific spot ratio, or proceed directly to treating a strongly suspected deficiency while investigating the cause. The BUN-to-creatinine ratio guide gives useful context for hydration and kidney-related lab interpretation.
An unusually high urinary metabolite result most often reflects recent niacin or niacinamide exposure. It is not a validated marker of “better cellular energy,” and it does not prove toxicity; toxicity is inferred from dose, symptoms, and safety labs such as transaminases, bilirubin, glucose, and uric acid.
Kantesti AI can compare lab results across visits and highlight whether ALT, HbA1c, uric acid, or eGFR shifted after a supplement was started. Our clinical validation approach emphasizes that trend recognition is decision support, while the diagnosis and treatment decision remain with the treating clinician.
Treatment and retesting after suspected deficiency
Clinicians usually use nicotinamide rather than nicotinic acid to treat suspected pellagra because it corrects deficiency without the same flushing burden. Typical therapeutic regimens are clinician-directed and commonly total about 300 mg/day in divided doses, alongside nutrition and treatment of the cause.
Nicotinamide doses around 100 mg three times daily have historically been used for pellagra treatment, often for several weeks, but the correct dose and duration depend on severity, liver disease, kidney function, pregnancy, other deficiencies, and the presumed cause. This is not the same as starting over-the-counter nicotinic acid for cholesterol or energy.
Dermatitis, appetite, mouth soreness, and diarrhoea may begin improving within days when deficiency is the cause, whereas cognitive recovery can take longer and needs close observation. In severe malnutrition, thiamine, folate, B12, magnesium, phosphate, and potassium also need consideration; isolated vitamin treatment can miss clinically significant refeeding physiology.
Retesting is individualized. A repeat 24-hour 1-MN result may be useful after nutritional rehabilitation or when absorption remains uncertain, while weight, bowel frequency, skin findings, CBC, electrolytes, and albumin may be more useful objective markers. Our blood-test trend guide explains why a consistent laboratory and comparable timing improve follow-up.
Why consumer vitamin panels can mislead
A consumer panel that reports a “niacin level” may not diagnose deficiency, pellagra, or supplement toxicity unless its method and reference interval are clinically validated. The name of a biomarker is not enough; specimen type, analytic method, and intended use matter.
Serum, plasma, whole blood, and urine measure different biological compartments and cannot be interpreted using interchangeable targets. A sample collected after a fortified drink or B-complex capsule may show recent exposure rather than cellular adequacy. That distinction is especially relevant for NAD-related commercial assays, which remain difficult to standardize across laboratories.
Before acting on an out-of-range result, ask three questions: What molecule was measured? What specimen was used? What condition has this assay been validated to detect? For a broader explanation of laboratory flags and reference intervals, review what “out of range” means.
Kantesti’s neural network reads the laboratory name, units, reference interval, collection date, and related conventional markers before generating an explanation. Kantesti is an AI-powered blood test analysis tool designed to make reports easier to discuss with a clinician; it does not convert an experimental wellness marker into a medical diagnosis.
When symptoms need urgent care rather than more testing
Confusion, fainting, inability to keep fluids down, jaundice, severe weakness, or rapidly worsening diarrhoea requires urgent medical assessment rather than waiting for a niacin test. These symptoms can reflect dehydration, liver injury, electrolyte disturbance, infection, neurological illness, or severe malnutrition.
Jaundice or dark urine after high-dose nicotinic acid is a same-day concern, especially with nausea, abdominal discomfort, or an ALT/AST elevation. Stop non-prescribed supplements until reviewed, but do not stop prescribed medicines without speaking to the prescriber or urgent-care team. Our guide to when bilirubin needs attention describes the warning pattern.
Confusion with diarrhoea can develop from sodium, potassium, magnesium, glucose, kidney, or liver abnormalities even when pellagra is being considered. A basic metabolic panel, glucose check, CBC, liver tests, and hydration assessment may be more urgent than specialized metabolite testing. This is one of those situations where clinical examination genuinely changes the meaning of the numbers.
As of July 30, 2026, my advice is to use specialized B3 testing selectively and keep the diagnostic question clear: deficiency, excess exposure, or a cause of malnutrition. Kantesti is an AI biomarker interpretation platform that helps organize conventional lab patterns for discussion with clinicians, supported by our medical advisory board; it is not an emergency service or a substitute for in-person care.
Frequently Asked Questions
Is there a blood test for niacin deficiency?
There is no widely standardized routine blood test that reliably diagnoses niacin deficiency in everyday practice. Specialized laboratories may measure whole-blood NAD/NADP or plasma niacin-related compounds, but reference intervals and clinical cutoffs are not harmonized. A 24-hour urine N1-methylnicotinamide test is more established for recent niacin status, with excretion below 0.5 mg/day supporting severe depletion when the collection is complete. Clinicians still diagnose pellagra primarily from symptoms, diet, risk factors, and treatment response.
What is a normal niacin test result?
For a 24-hour urinary N1-methylnicotinamide assay, excretion of at least 1.6 mg/day, approximately 10.1 µmol/day, is generally considered compatible with adequate recent niacin availability in historical nutritional criteria. Results of 0.5–1.59 mg/day are low, while values below 0.5 mg/day support severe depletion. Laboratories may use different analytical methods and reference intervals, particularly for spot urine samples normalized to creatinine. A normal result does not by itself exclude pellagra when symptoms and risk factors are compelling.
Can a multivitamin affect a niacin test?
Yes, a multivitamin containing 14–20 mg of niacin can raise recent urinary niacin metabolite excretion and may make a deficiency test appear more reassuring than the longer-term nutritional picture. A 500 mg nicotinic acid or niacinamide product can have a much larger effect because it supplies more than 14 times the adult supplemental upper intake level of 35 mg/day. Patients should list every vitamin, energy product, fortified drink, and prescribed lipid medicine for the clinician and laboratory. Do not stop prescribed treatment before testing unless the ordering clinician advises it.
How do doctors diagnose pellagra?
Doctors diagnose pellagra from a compatible clinical pattern: photosensitive symmetric dermatitis, diarrhoea or painful mouth symptoms, neuropsychiatric changes, and a history suggesting inadequate niacin intake or absorption. Urinary N1-methylnicotinamide below 0.5 mg/day can support severe depletion, but it is not a definitive stand-alone diagnostic test. The assessment also excludes mimics such as zinc deficiency, lupus, porphyria, coeliac disease, inflammatory bowel disease, and medication reactions. Improvement after supervised nicotinamide treatment provides additional support for the diagnosis.
What labs should be monitored with high-dose niacin?
People using pharmacologic nicotinic acid, commonly 1,000–2,000 mg/day, are usually monitored with ALT, AST, bilirubin, fasting glucose or HbA1c, and uric acid. Creatine kinase may be added when muscle pain or weakness occurs, particularly if a statin is also used. ALT or AST above three times the laboratory upper limit, especially with jaundice or dark urine, needs prompt medical assessment. A high serum niacin concentration is not the standard safety test for toxicity.
Can too much niacin damage the liver?
Yes, high-dose nicotinic acid can cause clinically significant liver injury, with sustained-release formulations carrying particular concern. The risk is generally associated with doses far above dietary requirements, often 1,000 mg/day or more, rather than niacin from food. Warning symptoms include nausea, marked fatigue, right-upper abdominal discomfort, dark urine, and yellow eyes or skin; liver enzyme elevations may occur before symptoms. Anyone taking a non-prescribed high-dose product should discuss it with a clinician rather than escalating or changing the formulation independently.
Get AI-Powered Blood Test Analysis Today
Join over 2 million users worldwide who trust Kantesti for instant, accurate lab test analysis. Upload your blood test results and receive comprehensive interpretation of 15,000+ biomarkers in seconds.
📚 Referenced Research Publications
Klein, T., Mitchell, S., & Weber, H. (2026). Kantesti LTD. (2026). B Negative Blood Type, LDH Blood Test & Reticulocyte Count Guide. Figshare. https://doi.org/10.6084/m9.figshare.31333819. Kantesti AI Medical Research.
Klein, T., Mitchell, S., & Weber, H. (2026). Kantesti LTD. (2026). Diarrhea After Fasting, Black Specks in Stool & GI Guide 2026. Figshare. https://doi.org/10.6084/m9.figshare.31438111. Kantesti AI Medical Research.
📖 External Medical References
⚕️ Medical Disclaimer
This article is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider for diagnosis and treatment decisions.
E-E-A-T Trust Signals
Experience
Physician-led clinical review of lab interpretation workflows.
Expertise
Laboratory medicine focus on how biomarkers behave in clinical context.
Authoritativeness
Written by Dr. Thomas Klein with review by Dr. Sarah Mitchell and Prof. Dr. Hans Weber.
Trustworthiness
Evidence-based interpretation with clear follow-up pathways to reduce alarm.